12390 El Camino Real
San Diego, CA 92130
United States
858 794 8889
https://halozyme.com
Setor(es): Healthcare
Indústria: Biotechnology
Funcionários Integrais: 373
Nome | Título | Pagar | Exercido | Nascido em |
---|---|---|---|---|
Dr. Helen I. Torley M.B. Ch. B., M.R.C.P. | President, CEO & Director | 1,82M | 5,69M | 1963 |
Ms. Nicole LaBrosse | Senior VP & CFO | 849,36k | N/A | 1983 |
Dr. Michael J. LaBarre Ph.D. | Senior VP & Chief Technical Officer | 843,89k | 2,6M | 1964 |
Mr. Mark Snyder Esq. | Senior VP & Chief Legal Officer | 912,87k | N/A | N/A |
Ms. Cortney Caudill M.B.A. | Chief Operations Officer | N/A | N/A | N/A |
Ms. Tram Bui | Head of Investor Relations & Corporate Communications | N/A | N/A | N/A |
Ms. Amy Marinne Fox | Senior Vice President of Human Resources | N/A | N/A | N/A |
Ms. Kristin Schwartzbauer | Head of Quality | N/A | N/A | N/A |
Mr. Gary Grote | Chief Commercial Officer | N/A | N/A | N/A |
Dr. Christopher Wahl M.B.A., M.D. | Chief Business Officer | N/A | N/A | N/A |
O QualityScore de governança da ISS da Halozyme Therapeutics, Inc. a partir de 1 de abril de 2024 é 1. As principais pontuações para Auditoria são: 4; Conselho: 1; Direitos de Acionistas: 3; Compensação: 1.